Dr. Visani on Tosedostat and Cytarbine in Elderly Patients With AML
December 21st 2015
Guiseppe Visani, MD, director, Hematology and Stem Cell Transplant Center at AORMN, Pesaro, Italy, discusses a phase II study examining the efficacy of tosedostat plus low-dose cytarabine in elderly patients with acute myeloid leukemia.